
Andrew J. Steinle
Examiner (ID: 11228, Phone: (571)272-9923 , Office: P/2497 )
| Most Active Art Unit | 2497 |
| Art Unit(s) | 2497 |
| Total Applications | 793 |
| Issued Applications | 704 |
| Pending Applications | 65 |
| Abandoned Applications | 65 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7200447
[patent_doc_number] => 20050165010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Use of substituted pteridines for the treatment of respiratory diseases'
[patent_app_type] => utility
[patent_app_number] => 11/034281
[patent_app_country] => US
[patent_app_date] => 2005-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4109
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20050165010.pdf
[firstpage_image] =>[orig_patent_app_number] => 11034281
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/034281 | Use of substituted pteridines for the treatment of respiratory diseases | Jan 11, 2005 | Abandoned |
Array
(
[id] => 7168103
[patent_doc_number] => 20050201949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 11/023015
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4050
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20050201949.pdf
[firstpage_image] =>[orig_patent_app_number] => 11023015
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/023015 | Pharmaceutical formulations | Dec 20, 2004 | Abandoned |
| 10/991573 | Methods and compositions for the treatment of metabolic disorders | Nov 16, 2004 | Abandoned |
Array
(
[id] => 7020117
[patent_doc_number] => 20050222136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Active substance combination'
[patent_app_type] => utility
[patent_app_number] => 10/987803
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11883
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222136.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987803
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987803 | Active substance combination | Nov 11, 2004 | Abandoned |
Array
(
[id] => 7111685
[patent_doc_number] => 20050209141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Mast cell-derived renin'
[patent_app_type] => utility
[patent_app_number] => 10/964567
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 22636
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209141.pdf
[firstpage_image] =>[orig_patent_app_number] => 10964567
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/964567 | Mast cell-derived renin | Oct 12, 2004 | Abandoned |
Array
(
[id] => 6997440
[patent_doc_number] => 20050137218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists'
[patent_app_type] => utility
[patent_app_number] => 10/957426
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12753
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137218.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957426
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957426 | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists | Sep 29, 2004 | Issued |
Array
(
[id] => 7216091
[patent_doc_number] => 20050054614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Methods of inhibiting leukocyte accumulation'
[patent_app_type] => utility
[patent_app_number] => 10/918825
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19641
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054614.pdf
[firstpage_image] =>[orig_patent_app_number] => 10918825
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/918825 | Methods of inhibiting leukocyte accumulation | Aug 12, 2004 | Abandoned |
Array
(
[id] => 5739033
[patent_doc_number] => 20060009424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Nasaleaze'
[patent_app_type] => utility
[patent_app_number] => 10/710382
[patent_app_country] => US
[patent_app_date] => 2004-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009424.pdf
[firstpage_image] =>[orig_patent_app_number] => 10710382
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/710382 | Nasaleaze | Jul 5, 2004 | Abandoned |
Array
(
[id] => 7122970
[patent_doc_number] => 20050014799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Pyridoxamine for the treatment of diabetic kidney disease'
[patent_app_type] => utility
[patent_app_number] => 10/871224
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4617
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014799.pdf
[firstpage_image] =>[orig_patent_app_number] => 10871224
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/871224 | Pyridoxamine for the treatment of diabetic kidney disease | Jun 17, 2004 | Abandoned |
Array
(
[id] => 7427353
[patent_doc_number] => 20040229876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Quinoline derivatives and quinazoline derivatives having azolyl group'
[patent_app_type] => new
[patent_app_number] => 10/861446
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24168
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229876.pdf
[firstpage_image] =>[orig_patent_app_number] => 10861446
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/861446 | Quinoline derivatives and quinazoline derivatives having azolyl group | Jun 6, 2004 | Issued |
Array
(
[id] => 7155913
[patent_doc_number] => 20050026852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Method of augmenting the antitumor activity of anticancer agents'
[patent_app_type] => utility
[patent_app_number] => 10/844800
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4395
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10844800
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/844800 | Method of augmenting the antitumor activity of anticancer agents | May 12, 2004 | Abandoned |
Array
(
[id] => 7256442
[patent_doc_number] => 20040259863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Type 4 phosphodiesterase inhibitors and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/494379
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19422
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259863.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494379
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494379 | Type 4 phosphodiesterase inhibitors and uses thereof | Apr 29, 2004 | Abandoned |
Array
(
[id] => 7105170
[patent_doc_number] => 20050107349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Method for the treatment or prevention of respiratory disorders with a cyclooxygenase-2 inhibitor in combination with a muscarinic receptor antagonist and compositions therewith'
[patent_app_type] => utility
[patent_app_number] => 10/833658
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44728
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107349.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833658 | Method for the treatment or prevention of respiratory disorders with a cyclooxygenase-2 inhibitor in combination with a muscarinic receptor antagonist and compositions therewith | Apr 27, 2004 | Abandoned |
Array
(
[id] => 7409987
[patent_doc_number] => 20040176323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Pharmaceutical composition comprising lysophophatidic acid'
[patent_app_type] => new
[patent_app_number] => 10/475814
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2621
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176323.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475814 | Pharmaceutical composition comprising lysophophatidic acid | Apr 21, 2004 | Abandoned |
| 10/493207 | Medicament comprising combination of triazaspiro[5.5]undecane derivative with cytochrome p450 isozyme 3a4 inhibitor and/or p-glycoprotein inhibitor | Apr 19, 2004 | Abandoned |
Array
(
[id] => 7433893
[patent_doc_number] => 20040209916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Combination therapies'
[patent_app_type] => new
[patent_app_number] => 10/824315
[patent_app_country] => US
[patent_app_date] => 2004-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11262
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209916.pdf
[firstpage_image] =>[orig_patent_app_number] => 10824315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/824315 | Combination therapies | Apr 12, 2004 | Abandoned |
Array
(
[id] => 7432842
[patent_doc_number] => 20040162294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Therapeutic use of selective PDE10 inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/779212
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10048
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162294.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779212 | Therapeutic use of selective PDE10 inhibitors | Feb 12, 2004 | Abandoned |
Array
(
[id] => 7432832
[patent_doc_number] => 20040162293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Therapeutic use of selective PDE10 inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/778809
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9599
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162293.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778809 | Therapeutic use of selective PDE10 inhibitors | Feb 12, 2004 | Abandoned |
Array
(
[id] => 7150909
[patent_doc_number] => 20040171556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Methods for inhibiting proteasome'
[patent_app_type] => new
[patent_app_number] => 10/761990
[patent_app_country] => US
[patent_app_date] => 2004-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26478
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10761990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/761990 | Methods for inhibiting proteasome | Jan 20, 2004 | Abandoned |
Array
(
[id] => 7672861
[patent_doc_number] => 20040180918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Novel therapeutic method'
[patent_app_type] => new
[patent_app_number] => 10/484292
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4597
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10484292
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/484292 | Novel therapeutic method | Jan 19, 2004 | Abandoned |